Recombinant Protein Drugs
Springer Basel (Verlag)
978-3-7643-5904-1 (ISBN)
Pioneers and business.- Recombinant interferon - the 20th anniversary.- Combining science and business: from recombinant DNA to vaccines against hepatitis B virus.- First generation proteins.- Clotting factors VIII and IX.- Colony-stimulating factors: altering the practice of oncology.- Tissue-type plasminogen activator: helping patients with acute myocardial infarction.- Proteins with new functions: protein engineering.- Designing immunocytokines: genetically engineered fusion proteins for targeted immune therapy.- Further improvement of protein drugs.- Improving protein therapeutics: the evolution of the modern pharmacopoeia.- Principles of gene transfer and foreign protein expression for human gene therapy.- Short biographies.- List of approved "recombinant protein drugs".
Erscheint lt. Verlag | 1.8.2001 |
---|---|
Reihe/Serie | Milestones in Drug Therapy |
Zusatzinfo | X, 207 p. |
Verlagsort | Basel |
Sprache | englisch |
Maße | 155 x 235 mm |
Gewicht | 494 g |
Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
Schlagworte | Clinic • clinical trial • Development • Drug • drug discovery • Drugs • Future • gene therapy • Hepatitis • Interferon • Oncology • Pharmaceutical • Protein • Protein Engineering • Research |
ISBN-10 | 3-7643-5904-8 / 3764359048 |
ISBN-13 | 978-3-7643-5904-1 / 9783764359041 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich